Others

Outcome of Board Meeting - Modified Scheme of Amalgamation

| Updated on February 02, 2018 Published on February 17, 2017

Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2017 had inter-alia approved the modified/ altered Scheme of Merger of the Wholly Owned Subsidiary, M/s. Amrutanjan Pharmaessense Private Limited with the Parent Company, M/s. Amrutanjan Health Care Limited.

Pdf Link: Outcome of Board Meeting - Modified Scheme of Amalgamation

Source : BSE - www.bseindia.com

Published on February 17, 2017
This article is closed for comments.
Please Email the Editor